相关实验视频

Updated: Jun 23, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

在心力衰竭中miRNA的研究进展:预测和治疗

Bingyan Hou¹, Dan Yu, Haotian Bai

¹Key Laboratory of Chinese Materia Medica, Ministry of Education, Pharmaceutical College, Heilongjiang University of Chinese Medicine, Harbin, China.

Journal of cardiovascular pharmacology

|June 26, 2024

概括

微RNAs (miRNAs) 通过调节关键分子机制,在预测和治疗心力衰竭 (HF) 中起着至关重要的作用. 基于miRNA的疗法为预防和治疗心力衰竭提供了一个有希望的新途径.

科学领域:

生物医学科学生物医学科学
分子生物学分子生物学
心脏病学心脏病学

背景情况:

心力衰竭 (HF) 是一种复杂的临床综合征,具有显著的发病率和死亡率.
微RNAs (miRNAs) 是小型非编码RNAs,调节基因表达,并与各种心血管疾病有关.
了解miRNAs在HF中的作用对于开发新型治疗策略至关重要.

研究的目的:

审查miRNAs在心力衰竭 (HF) 的预测和治疗中的多方面的作用.
阐明miRNAs影响心脏亡,纤维化,缩和重塑的分子机制.
讨论基于miRNA的干预措施在HF管理和预后方面的潜力.

主要方法:

对调查心力衰竭中的miRNA研究的综合文献综述.
分析心脏病理生理学中由miRNAs调节的分子通路.
对基于miRNA的心力衰竭治疗的当前和新兴策略的评估.

主要成果:

miRNAs是细胞亡,心肌纤维化,心脏缩和心室重塑的关键调节者.
特定的miRNA显示出作为HF预测和预后的生物标志物的潜力.
miRNA干预策略在临床前和临床研究中显示出治疗潜力.

结论:

微RNA是分子病原和心力衰竭进展的组成部分.
基于miRNA的诊断和治疗代表了心血管医学的重大进步.
针对性miRNA疗法作为预防和治疗心力衰竭的新方法具有前景.

更多相关视频

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...